Literature DB >> 29196934

Allogeneic Transplant for Mycosis Fungoides in Patient with Wiskott-Aldrich Syndrome.

Marianna Criscuolo1,2, Luana Fianchi3, Patrizia Chiusolo3, Sabrina Giammarco3, Andrea Bacigalupo3, Livio Pagano3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 29196934     DOI： 10.1007/s10875-017-0467-6

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN： 0271-9142            Impact factor:   8.317


× No keyword cloud information.
  11 in total

Review 1.  High incidence of lymphomas in a subgroup of Wiskott-Aldrich syndrome patients.

Authors:  Anna Shcherbina; Fabio Candotti; Fred S Rosen; Eileen Remold-O'Donnell
Journal:  Br J Haematol       Date:  2003-05       Impact factor: 6.998

2.  Rapid response of nodular CD30-positive mycosis fungoides to brentuximab vedotin.

Authors:  Marianna Criscuolo; Luana Fianchi; Maria Teresa Voso; Livio Pagano
Journal:  Br J Haematol       Date:  2014-11-18       Impact factor: 6.998

Review 3.  European Organisation for Research and Treatment of Cancer consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome - Update 2017.

Authors:  Franz Trautinger; Johanna Eder; Chalid Assaf; Martine Bagot; Antonio Cozzio; Reinhard Dummer; Robert Gniadecki; Claus-Detlev Klemke; Pablo L Ortiz-Romero; Evangelia Papadavid; Nicola Pimpinelli; Pietro Quaglino; Annamari Ranki; Julia Scarisbrick; Rudolf Stadler; Liisa Väkevä; Maarten H Vermeer; Sean Whittaker; Rein Willemze; Robert Knobler
Journal:  Eur J Cancer       Date:  2017-03-31       Impact factor: 9.162

4.  Successful treatment of non-Hodgkin's lymphoma using R-CHOP in a patient with Wiskott-Aldrich syndrome followed by a reduced-intensity stem cell transplant.

Authors:  Yuhki Koga; Hidetoshi Takada; Aiko Suminoe; Shouichi Ohga; Toshiro Hara
Journal:  Pediatr Transplant       Date:  2014-06-14

5.  Prospective international multicenter phase II trial of intravenous pegylated liposomal doxorubicin monochemotherapy in patients with stage IIB, IVA, or IVB advanced mycosis fungoides: final results from EORTC 21012.

Authors:  Reinhard Dummer; Pietro Quaglino; Jürgen C Becker; Baktiar Hasan; Matthias Karrasch; Sean Whittaker; Stephen Morris; Michael Weichenthal; Rudolf Stadler; Martine Bagot; Antonio Cozzio; Maria G Bernengo; Robert Knobler
Journal:  J Clin Oncol       Date:  2012-10-08       Impact factor: 44.544

6.  Successful allogeneic hemopoietic stem cell transplantation in a case of Wiskott-Aldrich syndrome and non-Hodgkin lymphoma.

Authors:  Betul Tavil; Arzu Yazal Erdem; Fatih Azik; Pamir Isik; Ayse Metin; Suna Emir; Duygu Uckan; Bahattin Tunc
Journal:  Pediatr Transplant       Date:  2013-06-17

7.  Mutations of the Wiskott-Aldrich Syndrome Protein (WASP): hotspots, effect on transcription, and translation and phenotype/genotype correlation.

Authors:  Yinzhu Jin; Cinzia Mazza; Jacinda R Christie; Silvia Giliani; Maurilia Fiorini; Patrizia Mella; Francesca Gandellini; Donn M Stewart; Qili Zhu; David L Nelson; Luigi D Notarangelo; Hans D Ochs
Journal:  Blood       Date:  2004-07-29       Impact factor: 22.113

8.  Long-term outcome and lineage-specific chimerism in 194 patients with Wiskott-Aldrich syndrome treated by hematopoietic cell transplantation in the period 1980-2009: an international collaborative study.

Authors:  Daniele Moratto; Silvia Giliani; Carmem Bonfim; Evelina Mazzolari; Alain Fischer; Hans D Ochs; Andrew J Cant; Adrian J Thrasher; Morton J Cowan; Michael H Albert; Trudy Small; Sung-Yun Pai; Elie Haddad; Antonella Lisa; Sophie Hambleton; Mary Slatter; Marina Cavazzana-Calvo; Nizar Mahlaoui; Capucine Picard; Troy R Torgerson; Lauri Burroughs; Adriana Koliski; Jose Zanis Neto; Fulvio Porta; Waseem Qasim; Paul Veys; Kristina Kavanau; Manfred Hönig; Ansgar Schulz; Wilhelm Friedrich; Luigi D Notarangelo
Journal:  Blood       Date:  2011-06-09       Impact factor: 22.113

9.  Allogeneic hematopoietic cell transplantation for mycosis fungoides and Sezary syndrome.

Authors:  M J Lechowicz; H M Lazarus; J Carreras; G G Laport; C S Cutler; P H Wiernik; G A Hale; D Maharaj; R P Gale; P A Rowlings; C O Freytes; A M Miller; J M Vose; R T Maziarz; S Montoto; D G Maloney; P N Hari
Journal:  Bone Marrow Transplant       Date:  2014-07-28       Impact factor: 5.483

Review 10.  Targeted therapy for Hodgkin lymphoma and systemic anaplastic large cell lymphoma: focus on brentuximab vedotin.

Authors:  Xueyan Chen; Lorinda A Soma; Jonathan R Fromm
Journal:  Onco Targets Ther       Date:  2013-12-19       Impact factor: 4.147
View more
  1 in total

1.  Mycosis Fungoides: Analysis of Ophthalmologic Findings in a Series of Cases.

Authors:  Carina G Colossi; Juliano Mondadori; Pedro K M Barreto; Felipe M Valença; Rodrigo Duquia; Manuel A P Vilela
Journal:  Case Rep Dermatol Med       Date:  2019-01-20
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.